Bank Of America Corp Aspira Women'S Health Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.32 - $0.58 $204 - $370	638 Added 176.24%	1,000 $0
Q4 2022 Feb 10, 2023	BUY	$0.3 - $0.41 $47 - $64	158 Added 77.45%	362 $0
Q3 2022 Nov 14, 2022	BUY	$0.38 - $1.07 $56 - $158	148 Added 264.29%	204 $0
Q2 2022 Aug 12, 2022	SELL	$0.4 - $1.09 $10,085 - $27,483	-25,214 Reduced 99.78%	56 $0
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $107,017 - $220,115	-121,611 Reduced 82.8%	25,270 $26,000
Q4 2021 Feb 08, 2022	BUY	$1.63 - $3.43 $1,905 - $4,009	1,169 Added 0.8%	146,881 $260,000
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $288,666 - $495,890	90,491 Added 163.87%	145,712 $473,000
Q2 2021 Sep 13, 2021	BUY	$4.78 - $6.84 $263,956 - $377,711	55,221 New	55,221 $310,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.